References
- F Waldmeier, U Glaenzel, B Wirz, L Oberer, D Schmid, M Seiberling, J Valencia, GJ Riviere, P End, and S Vaidyanathan. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers. Drug Metabol Disposit 2007; 35:1418–1428.
- HA Spiller, TM Udicious, and S Muir. Angiotensin converting enzyme inhibitor ingestion in children. J Toxicol Clin Toxicol 1989; 27:345–353.
- CP Lau. Attempted suicide with enalapril. N Engl J Med 1986; 315:197.
- P Lechleitner, A Dzien, and C Haring. Uneventful self poisoning with a very high dose of captopril. Toxicology 1990; 64:325–329.
- A Stanton, C Jensen, J Nussberger, and E Obrien. Blood Pressure lowering in Essential Hypertension with an Oral Renin Inhibitor, Aliskiren. Hypertension 2003; 42:1137–1143.
- J Framme, F Dangardt, S Marild, W Osika, P Wahrborg, and P Friberg. 24-H systolic blood pressure and heart rate recordings in lean and obese adolescents. Clin Physiol Funct Imaging 2006; 26:235–239.
- GA Harshfield, ME Wilson, FA Treiber, and BS Alpert. A comparison of ambulatory blood pressure patterns across populations. Blood Press Monit 2002; 7:265–269.
- GA Harshfield, FA Treiber, Wilson, Kapulu, and HC Davis. A longitudinal study of ethnic deferences in ambulatory blood pressure patterns in youth. Amer J Hypertens 2002; 15:525–530.